Literature DB >> 6333185

The role of neutrophils in type II collagen-induced arthritis in rats.

D Schrier, R B Gilbertsen, M Lesch, J Fantone.   

Abstract

Type II collagen-induced arthritis is a pathologic process mediated, in part, by humoral immune mechanisms. Because many antibody-mediated reactions are neutrophil-dependent, the role of this cell population was examined in collagen arthritis. In rats depleted of neutrophils with rabbit anti-rat neutrophil antiserum (ANS), swelling and inflammation associated with the arthritis response were maximally reduced by 65% (P less than 0.001). ANS treatment had no detectable effect on delayed hypersensitivity or antibody response to Type II collagen. Also, levels of peripheral blood monocytes, lymphocytes, and platelets were unaffected. Treatment with normal rabbit serum (NS) had no detectable effect on any of the inflammatory or immune parameters tested nor on circulating levels of monocytes, lymphocytes, or platelets. These results suggest that further study of the functions of neutrophils in rat collagen arthritis may be of help in our understanding of the role of this cell population in human arthritis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333185      PMCID: PMC1900570     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  15 in total

1.  Passive transfer by cells of type II collagen-induced arthritis in rats.

Authors:  D E Trentham; R A Dynesius; J R David
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

2.  Further speculation on the pathogenesis of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

Review 3.  Lysosomes and joint disease.

Authors:  G Weissmann
Journal:  Arthritis Rheum       Date:  1966-12

4.  Enzyme-linked immunosorbent microassay for quantification of specific antibodies to collagen type I, II, III.

Authors:  B Gosslau; H J Barrach
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

5.  Biochemical and physiochemical characterization of pepsin-solubilized type-II collagen from bovine articular cartilage.

Authors:  D Herbage; J Bouillet; J C Bernengo
Journal:  Biochem J       Date:  1977-02-01       Impact factor: 3.857

6.  Cellular sensitivity to collagen in rheumatoid arthritis.

Authors:  D E Trentham; R A Dynesius; R E Rocklin; J R David
Journal:  N Engl J Med       Date:  1978-08-17       Impact factor: 91.245

7.  Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats.

Authors:  D E Trentham; A S Townes; A H Kang; J R David
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

8.  Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis.

Authors:  R B Clague; M J Shaw; P J Holt
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

9.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

10.  Release of cartilage mucopolysaccharide-degrading neutral protease from human leukocytes.

Authors:  A Oronsky; L Ignarro; R Perper
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

View more
  9 in total

1.  Improvement in rheumatoid arthritis following application of an extracorporeal granulotrap column, G-1.

Authors:  J Fujimori; S Yoshino; M Koiwa; H Hirai; H Shiga; N Hayama; Y Iino
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

2.  The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis.

Authors:  Anna M Ritzman; Jennifer M Hughes-Hanks; Victoria A Blaho; Laura E Wax; William J Mitchell; Charles R Brown
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

3.  The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibody.

Authors:  Prapaporn Pisitkun; Estefania Claudio; Nina Ren; Hongshan Wang; Ulrich Siebenlist
Journal:  Arthritis Rheum       Date:  2010-11

4.  The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen-induced arthritis in mice.

Authors:  K Kakimoto; Y Kojima; K Ishii; K Onoue; H Maeda
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

5.  Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.

Authors:  R J Griffiths; E R Pettipher; K Koch; C A Farrell; R Breslow; M J Conklyn; M A Smith; B C Hackman; D J Wimberly; A J Milici
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

Review 6.  Apocynin, a low molecular oral treatment for neurodegenerative disease.

Authors:  Bert A 't Hart; Sjef Copray; Ingrid Philippens
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

Review 7.  Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma.

Authors:  Mary Claire Rolfes; Young Jun Juhn; Chung-Il Wi; Youn Ho Sheen
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-03-31

8.  IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints.

Authors:  Sudeepta Kumar Panda; Gustaf Wigerblad; Long Jiang; Yanek Jiménez-Andrade; Vaishnavi Srinivasan Iyer; Yunbing Shen; Sanjaykumar V Boddul; André Ortlieb Guerreiro-Cacais; Bruno Raposo; Zsolt Kasza; Fredrik Wermeling
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-24       Impact factor: 11.205

9.  Pentosan polysulfate sodium prevents functional decline in chikungunya infected mice by modulating growth factor signalling and lymphocyte activation.

Authors:  Penny A Rudd; Elisa X Y Lim; Catherine J M Stapledon; Ravi Krishnan; Lara J Herrero
Journal:  PLoS One       Date:  2021-09-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.